Status:
COMPLETED
Accessible Weight Loss for Adults With Low Vision: A Feasibility Study
Lead Sponsor:
Towson University
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the feasibility of an all-remote approach to enrollment in and implementation of an 8-week weight loss program for adults with low vision. The weight loss program will provide ...
Eligibility Criteria
Inclusion
- Age ≥18
- English speaking
- BMI ≥ 25 and weight \< 300lbs (weight limit due to scale limitations)
- Legally blind
- Have an email for personal use and ability to check and respond to email daily
- Have a smart phone with texting for personal use
- Sufficient internet plan for daily email checking
- Sufficient phone plan for 12 or more texts per week
- Ability to send and receive emails and text messages
- Ability to join a zoom call on a personal phone, tablet, or computer
- Ability to complete Qualtrics surveys
- Willing to lose weight through recommended dietary changes, weight tracking and physical activity
- Interest in one of the specific dietary strategies supported by the text messaging platform
- Willing to use the study scale with cellular technology to report weights
- Willing to join an 8-week weight loss program and interested in losing weight
- Completion of screening, enrollment and baseline data collection
Exclusion
- Lost 5% of body weight in the last 6 months
- Currently participating in a weight loss program or another weight loss study
- Previously diagnosed eating disorder, or treatment for an eating disorder
- Pregnant, nursing, or planned pregnancy in the next 6 months
- Planned weight loss surgery or procedure in the next 6 months
- Currently using medication for weight loss (prescribed or over the counter)
- History of cardiovascular events
- History of type 1 or type 2 diabetes
- Prescribed medication that might promote weight change such as lithium, steroids, or antipsychotics
- Medical contraindicate to weight loss (e.g., end-stage renal disease, cancer diagnosis with active/planned treatment)
- Psychiatric hospitalization in the past 12 months
- Investigator discretion for safety or to ensure appropriate treatment of study staff
Key Trial Info
Start Date :
June 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05419063
Start Date
June 6 2022
End Date
January 31 2023
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Towson University
Towson, Maryland, United States, 21252